| Document |
Document Title |
|
WO/2018/088497A1 |
A polyamide resin with excellent balance of mechanical characteristics such as breaking strength and breaking elongation in a solid state, a molded body containing said polyamide resin, a laminate provided with a film or sheet containing...
|
|
WO/2018/084694A1 |
The present Invention' relates to a method of preparing reduced grapheme oxide, Incorporation of the adduced graphene oxide into polysioprene latex to provide a polyisoprene latex graphene composite and elastomerk articles prepared using...
|
|
WO/2018/083623A1 |
The present invention relates to the medical industry. In particular, the invention relates to a functionalised polyvinyl chloride (PVC) polymer for medical use, which is flexible and compatible with blood. The invention relates specific...
|
|
WO/2018/081515A1 |
A conductive coating may be adhered to a structure comprising a hydrophobic and/or adhesion-resistant surface. The conductive coating may have a polymer backbone with conductive particles suspended in the backbone. In some embodiments, t...
|
|
WO/2018/074074A1 |
Provided is a catheter assembly having a distal end portion which is highly flexible and also has an X-ray contrast property. A catheter assembly 1 has an outer catheter 2 having an elongated tubular outer shaft 3 and an inner catheter 5...
|
|
WO/2018/075552A1 |
A device for reducing pulsatile pressure within a vessel to treat heart disease, such as pulmonary hypertension, includes a compliant body structured to expand and contract upon changes in pressure within the vessel, a reservoir structur...
|
|
WO/2018/075360A1 |
Medical appliances including reinforcing bands and radiopaque marker bands are disclosed. In some embodiments, bands within the scope of this disclosure may comprise two or more material layers. A first layer may control the mechanical p...
|
|
WO/2018/071458A1 |
A sheath introducer facilitates the insertion of a catheter into a peripheral artery. The sheath introducer comprises longitudinally extending exterior and interior surfaces, the interior surface defining a lumen in which blood flow occu...
|
|
WO/2018/064445A1 |
Compositions that are suitable for use as a disinfectant are disclosed. Methods of making and using compositions that are suitable for use as a disinfectant are also disclosed.
|
|
WO/2018/059207A1 |
Disclosed is use of amlexanox or a salt thereof or a solvate thereof in preparation of a drug having an inhibitory action on the smooth muscle cells, in particular a drug for preventing and treating vascular restenosis. Further disclosed...
|
|
WO/2018/059167A1 |
A drug-coated balloon, comprising a balloon body and a drug coating covering the surface of the balloon body. The drug coating comprises an active drug and a carrier, the active drug comprising an anti-proliferative drug and the carrier ...
|
|
WO/2018/056344A1 |
Provided is a two pack type coating agent for medical devices, which improves the initial water wettability of a biocompatible coating film that is formed from a water-insoluble phosphorylcholine group-containing polymer. The present inv...
|
|
WO/2018/057867A1 |
Components of medical devices include polyethylene-poly(ethylene oxide) amphiphilic graft copolymers (PE-g-PEO) in their base polymer formulations. The base polymeric formulations comprise at least a polymer or co-polymer of ethylene. Th...
|
|
WO/2018/053407A1 |
The present invention relates to novel aminobisphosphonate compounds useful as antiwear and/or friction modifier additive components, lubricant additive compositions and lubricant compositions each comprising such compounds, and methods ...
|
|
WO/2018/050453A1 |
In order to reduce the risk of infection in medical establishments, the surface (10, 15) of a medical device (6, 7) having a surface (10, 15) that runs the risk of being contaminated is provided with a self-disinfecting property. For thi...
|
|
WO/2018/043622A1 |
[Problem] To provide a ceramic particle releasable composite material that reduces biocompatibility reduction and solubility changes as much as possible and has calcium phosphate sintered particles having a smaller particle size. [Soluti...
|
|
WO/2018/044839A1 |
Methods of varying the stiffness of polymeric medical tubes.
|
|
WO/2018/043620A1 |
[Problem] To provide a ceramic particle carrying medical tube and/or cuff that has excellent cell adhesiveness, etc. [Solution] A medical tube and/or cuff carrying ceramic particles in at least part thereof and characterized by: the part...
|
|
WO/2018/038063A1 |
[Problem] To provide a hydrophilic copolymer which is capable of forming a surface lubricating layer that exhibits excellent lubricity and durability (lubricity retention). In addition, to provide a hydrophilic copolymer which exhibits g...
|
|
WO/2018/039582A1 |
Embodiments of the present disclosure provide for lubricious structures (also referred to simply as "structure"), methods of making lubricious structures, methods of using lubricious structures, and the like.
|
|
WO/2018/033664A1 |
The present invention relates to a method and installation for handling medical waste, bio-waste, or other corresponding contaminated waste, which is collected in a receptacle for medical waste. For an isolated treatment of the waste, th...
|
|
WO/2018/028831A1 |
The present invention relates in a first alternative to a composition for preventing or retarding degradation of a functional coating on a medical device comprising an antioxidant selected from gallic acid or a derivative thereof. The pr...
|
|
WO/2018/029279A1 |
The present invention relates to a method of producing a ready-to-use medical device with a functional coating comprising the steps of bringing the medical device, at least with its functional coating, in contact with a composition which...
|
|
WO/2018/025968A1 |
This catheter assembly (10) is provided with: a catheter (20) having, along the central axis thereof, an inner cavity (20a); and an inner needle (50) retractably inserted through the inner cavity (20a). The inner needle (50) includes: an...
|
|
WO/2018/019055A1 |
Disclosed are a compound drug for a drug-loaded balloon for diseased artery vasodilatation and the drug-loaded balloon. The compound drug comprises the following raw materials: a lipophilic active drug for treating arterial blood vessel ...
|
|
WO/2018/011824A1 |
The present invention disclose a method for preventing retraction of aqueous drops on a hydrophobic surface. The present invention also discloses a medical device coated with a hydrophilic coating comprising a substrate and a coating com...
|
|
WO/2018/013805A2 |
Hygienic Hydrophilic coatings, hydrophilic coating formulations and wetting fluids that include an anti-infective agent.
|
|
WO/2018/013581A1 |
Hand held and portable disinfection units for use with patients having indwelling catheters hospitalized or under care in an intensive care unit.
|
|
WO/2018/013190A1 |
An apparatus for and method of manufacturing an improved wire-reinforced plastic tubing for medical and other applications is disclosed. A plurality of spaced-apart wire segments may be wound onto successive portions of a long segment of...
|
|
WO/2018/008518A1 |
The present invention provides: a balloon catheter configured so that, during the delivery of medicine, the dissolution of medicine into blood or the dropping off of the medicine can be prevented; and a method for manufacturing the ballo...
|
|
WO/2018/009684A1 |
A plasticized nylon and a medical device including plasticized nylon. The medical device may be a dilatation balloon. Also disclosed are methods of plasticizing nylon.
|
|
WO/2018/008517A1 |
Provided is a drug-eluting balloon catheter that, during delivery of a balloon in the drug-eluting balloon catheter, to a lesion, is capable of inhibiting a drug held on the outside surface of a balloon from eluting into blood and from f...
|
|
WO/2018/005614A1 |
The present disclosure provides improved medical delivery devices for delivering a medical device into a subject. In one embodiment, the medical delivery device includes a non-porous composite inner layer constructed of a lubricious mate...
|
|
WO/2017/223544A2 |
Durable, anti-fouling, crosslinked zwitterionic coatings that are grafted to the surface of a substrate through covalent bonding are disclosed. When exposed to a light source, zwitterionic monomers react with a crosslinker and with activ...
|
|
WO/2017/223536A1 |
The present disclosure is directed toward drug coated balloons, and in particular to drug coated balloons having a microcrystalline structure and techniques for increasing vascular permeability for drug application and retention. Particu...
|
|
WO/2017/218684A1 |
This disclosure is directed to a medical device including a surface that has been roughened to provide a roughened surface that inhibits the adhesion of microorganisms on the roughened surface.
|
|
WO/2017/214592A1 |
The present invention relates to modification of cellulose nanofibrils (CNF) with extracellular matrix components such as collagen, elastin, fibronectin or RGD sequences or growth factors such as TGFBeta using for example EDS-NHS conjuga...
|
|
WO/2017/209222A1 |
The present invention relates to a method for producing a medical device having excellent wettability and high water resistance, by which a polymer coating film is able to be formed easily. According to the present invention, a base is p...
|
|
WO/2017/204306A1 |
Provided are a protein adhesion inhibitor that presents excellent protein non-adsorptivity and can form a cured product having excellent shape stability capable of suppressing the occurrence of warping even when a film is formed, a cured...
|
|
WO/2017/198822A1 |
A tube connection part adapted to accommodate a flexible tube made from a material comprising polyvinyl chloride, wherein said tube connection part comprises a sleeve adapted to form an overlapping region between said tube connection par...
|
|
WO/2017/198817A1 |
A flexible tube made from a material comprising polyvinyl chloride, wherein said tube which is fully or in part superimposed by an adhesion promoting agent comprising a styrene-butadiene block copolymer.
|
|
WO/2017/196368A1 |
Methods, systems, and kits provide robust and biologically active coatings for implanted medical devices. The methods are based on electrostatic attraction between a conductive or non-conductive material surface on the medical device and...
|
|
WO/2017/191555A1 |
The invention relates to the use of a mesoporous oxide film, synthesized by the sol-gel technique, self-assembly of surfactants and removal of the structuring agent by calcination, having a pore size of between approximately 4 nm and app...
|
|
WO/2017/191110A1 |
The present invention concerns a polyelectrolyte coating comprising at least one polycationic layer consisting of at least one polycation consisting of n repetitive units having the formula (1) and at least one polyanionic layer consisti...
|
|
WO/2017/189761A1 |
A composition, article, and method for increasing the hydrolytic stability of a polymer; wherein a composition includes: a polymer comprising functional groups having hydrolyzable bonds; a carbodiimide compound; and a weak base (or hinde...
|
|
WO/2017/189480A1 |
The present invention relates to novel compositions and methods for reducing or eliminating the thrombogenicity of a graft by modifying the graft with a cell-derived extracellular matrix lacking thrombospodin-2 (TSP2-null ECM) to render ...
|
|
WO/2017/180686A1 |
A medical device for insertion or implantation in a body includes a polymer substrate and a layer of poly(vinyl pyrrolidone-alt-maleic anhydride) formed on a surface of the polymer substrate. Polymer chains of the poly(vinyl pyrrolidone-...
|
|
WO/2017/175540A1 |
The present invention is a radiation-resistant resin additive containing as an active ingredient a bisphenol compound represented by general formula (1) or general formula (2), a radiation-resistant medical polyamide resin composition co...
|
|
WO/2017/172607A1 |
Delivery systems (100) for active agent coated balloons and related methods. A delivery system can include a tunneling sheath (104) and a balloon catheter (106). The tunneling sheath can include a tubular shaft (602) having an outer diam...
|
|
WO/2017/172974A1 |
The present disclosure relates generally to materials and medical devices impregnated with antimicrobial compounds. More specifically, the materials are medical matrix materials comprising nanopores or nanochannels in which the antimicro...
|
